• Institute for Clinical Systems Improvement (ICSI). Stable coronary artery disease. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2007 Apr. 45 p. [74 references]

Does not apply to this measure

This measure is used to assess the percentage of patients with stable coronary artery disease (CAD) who have aspirin use documented in the medical record.

The priority aim addressed by this measure is to improve selection and education of patients with stable coronary artery disease (CAD) on the use of aspirin and antianginal drugs.

Stable coronary artery disease (CAD); aspirin

All patients age 18 and over with stable coronary artery disease (CAD) (see the related "Denominator Inclusions/Exclusions" field in the Complete Summary)

Number of patient records containing documentation of aspirin use (see the related "Numerator Inclusions/Exclusions" field in the Complete Summary)

• A clinical practice guideline or other peer-reviewed synthesis of the clinical evidence

Unspecified

Current routine use

Internal quality improvement

Physician Group Practices/Clinics

Physicians

Group Clinical Practices

Age greater than or equal to 18 years

Either male or female

Unspecified

Unspecified

Unspecified

Unspecified

Unspecified

Unspecified

Living with Illness

Effectiveness

Users of care only

All patients age 18 and over with stable coronary artery disease (CAD)

Patients may be identified by using the procedure that follows.

Use a computer run to select patients with the suggested International Classification of Diseases, Ninth Revision (ICD-9) codes or the ICD-9 codes you determine your providers use to describe the type of patients included in the guideline. The medical records of these patients are reviewed for evidence that the patient is using low-dose aspirin on a regular basis. Data needs to be collected for at least 10 patients.

Count as patients in the denominator all patients whose records verify the stable CAD diagnosis. Count in the numerator all patients whose records contain documentation of regular use of low-dose aspirin.

Medical groups have the option to exclude patients with a documented contraindication to aspirin from this measure. It will be each medical group's determination whether the cost of doing this more specific measure is worth the benefit of the more precise result.

Data may be collected monthly.

Patients associated with provider

Inclusions
A patient will be age 18 and over

Stable coronary artery disease (CAD) patients may be identified by use of these suggested International Classification of Diseases, Ninth Revision (ICD-9) codes: 412.xx - 414.xx.

Exclusions
Patients should be excluded if there has been any visit with one or more of the following codes for acute myocardial infarction (MI) events within the past year: 410.xx - 411.xx.

Patients with documented contraindications to aspirin are included in the measure as it is written. Patients with documented contraindications to aspirin may be excluded from the denominator of this measure at the discretion of the individual medical group.

All cases in the denominator are equally eligible to appear in the numerator

Clinical Condition

Time window precedes index event

The measure results are somewhat or substantially under the control of the health care professionals, organizations and/or policymakers to whom the measure applies.

Fixed time period

Administrative data
Medical record

Individual Case

Unspecified

Rate

Better quality is associated with a higher score

Unspecified

Internal time comparison

Unspecified

Percentage of patients with stable CAD who have aspirin use documented in the medical record.

Institute for Clinical Systems Improvement

The following Minnesota health plans provide direct financial support: Blue Cross and Blue Shield of Minnesota, HealthPartners, Medica, Metropolitan Health Plan, PreferredOne and UCare Minnesota. In-kind support is provided by the Institute for Clinical Systems Improvement's (ICSI) members.

Work Group Members: Greg Lehman, MD (Work Group Leader) (Park Nicollet Clinic) (Internal Medicine); Greg Barsness, MD (Mayo Clinic) (Cardiology); Joe H. Nguyen, MD (CentraCare) (Cardiology); Dale Duthoy, MD (Family HealthServices Minnesota) (Family Medicine); Spencer Bershow, MD (Fairview Health Services) (Family Medicine); Phil Kofron, MD, MPH (Park Nicollet Clinic) (General Internist); Susan M. Hanson, RD (Park Nicollet Institute) (Health Education); Shauna Schad, RN, CNS (Mayo Clinic) (Nursing); Peter Marshall, PharmD (HealthPartners Medical Group) (Pharmacy); Raed D. Abughazaleh (University of Minnesota) (Pharmacy Student); Amy Murphy, MHHA (Institute for Clinical Systems Improvement) (Measurement Advisor); Ann-Marie Landin, BS, RHIT (Institute for Clinical Systems Improvement) (Facilitator)

Measure was not adapted from another source.

2003 Nov

2007 Apr

Please note: This measure has been updated. The National Quality Measures Clearinghouse is working to update this summary.

• Institute for Clinical Systems Improvement (ICSI). Stable coronary artery disease. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2007 Apr. 45 p. [74 references]

This NQMC summary was completed by ECRI on July 14, 2004. This NQMC summary was updated by ECRI June 9, 2005, June 29, 2006 and again on June 4, 2007.

This NQMC summary (abstracted Institute for Clinical Systems Improvement [ICSI] Measure) is based on the original measure, which is subject to the measure developer's copyright restrictions.

The abstracted ICSI Measures contained in this Web site may be downloaded by any individual or organization. If the abstracted ICSI Measures are downloaded by an individual, the individual may not distribute copies to third parties.

If the abstracted ICSI Measures are downloaded by an organization, copies may be distributed to the organization's employees but may not be distributed outside of the organization without the prior written consent of the Institute for Clinical Systems Improvement, Inc.

All other copyright rights in the abstracted ICSI Measures are reserved by the Institute for Clinical Systems Improvement, Inc. The Institute for Clinical Systems Improvement, Inc. assumes no liability for any adaptations or revisions or modifications made to the abstracts of the ICSI Measures.